Burgeoning biotech demanding more lab space
A growing demand for new biotech and lab space is forcing up rents in the Washington DC area as vacancies decline. Rockville, MD-based Scheer Partners expects vacancies to drop from 8 percent this year to 5 percent next year and three percent the following year. As a result, rents are projected to shoot up from $27 to $36 per square foot. Developers say more speculative lab space is likely to come on the market soon.
"Before, there was a lag period between mature companies and companies still rising," Pete Briskman, a vice president of The Staubach Co., told the Washington Business Journal. "We're seeing that lag being filled now by mid-stage companies."
- read the report on the Washington Business Journal
Related Article:
CDC lab inspection process under scrutiny. Report
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


